In vitro models for the prediction of in vivo performance of oral dosage forms

This publication has 203 references indexed in Scilit:

• Design of Lipid-Based Formulations for Oral Administration of Poorly Water-Soluble Drug Fenofibrate: Effects of Digestion
  AAPS PharmSciTech, 2012
• Luminal Lipid Phases after Administration of a Triglyceride Solution of Danazol in the Fed State and Their Contribution to the Flux of Danazol Across Caco-2 Cell Monolayers
  Molecular Pharmaceutics, 2012
• An Investigation into the Utility of a Multi-compartmental, Dynamic, System of the Upper Gastrointestinal Tract to Support Formulation Development and Establish Bioequivalence of Poorly Soluble Drugs
  The AAPS Journal, 2012
• FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms
  AAPS PharmSciTech, 2011
• Achieving Antral Grinding Forces in Biorelevant In Vitro Models: Comparing the USP Dissolution Apparatus II and the Dynamic Gastric Model with Human In Vivo Data
  AAPS PharmSciTech, 2011
• A biorelevant dissolution stress test device – background and experiences
  Expert Opinion on Drug Delivery, 2010
• Bio-Dis and the Paddle Dissolution Apparatuses Applied to the Release Characterization of Ketoprofen from Hypromellose Matrices
  AAPS PharmSciTech, 2009
• A Standardized Mini Paddle Apparatus as an Alternative to the Standard Paddle
  AAPS PharmSciTech, 2008
• In Vitro Studies are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-Release Solid Oral Dosage Forms
  The AAPS Journal, 2008
• In vitro–in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
  Biochemical Pharmacology, 2006